Vérification…
Traduit automatiquement. Doses et mises en garde : vérifiez l'original en anglais. Lire en anglais
Accueil / Enregistré au Nigeria / Jessy Haemoglobin Syrup

Jessy Haemoglobin Syrup

NAFDAC REG NO: A11-1301 Médicament

Enregistré auprès de NAFDAC. Enregistrement actifAs of 3 November 2026 · synced automatically from official sources.
Produit
Jessy Haemoglobin Syrup
Numéro NAFDAC
A11-1301
Principe actif
Haemoglobin; Chelated iron; Cyanocobalamin; Malt extract
Dosage
5%; 0.3%; 0.0004%; 2%
Forme
Syrup
Conditionnement
1 x 200 mL (in amber glass bottle)
Fabricant
Non répertorié
Déposant / Titulaire :
Jessy Pharmaceutical Company Limited
Approuvé
26 Jan 2023
Statut
Actif Vue sur NAFDAC ↗
Enregistrement valable jusqu'au
25 Jan 2028
Alertes OMS
Non trouvé
Community reports
None
Times checked
0

About the medicine: Haemoglobin: uses, dosage and brands worldwide

What we found

  • Jessy Haemoglobin Syrup is on the NAFDAC register with an active registration (A11-1301). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Jessy Haemoglobin Syrup

Ce que dit la notice officielle. Si un médecin vous l'a prescrit, suivez l'ordonnance. La notice de votre boîte prime si elle est différente.

Pour qui

Cyanocobalamin is indicated for vitamin B 12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency It may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see Drug/Laboratory Test Interactions ), use of a gluten-free diet in nontr …

Comment le prendre et à quelle fréquence
  • Avoid using the intravenous route
  • Use of this product intravenously will result in almost all of the vitamin being lost in the urine
  • Pernicious Anemia Parenteral vitamin B 12 is the recommended treatment and will be required for the remainder of the patient's life
  • The oral form is not dependable
  • A dose of 100 mcg daily for 6 or 7 days should be administered by intramuscular or deep subcutaneous injection
  • If there is clinical improvement and if a reticulocyte response is observed, the same amount may be given on alternate days for seven doses, then every 3 to 4 days for another 2 to 3 weeks
  • By this time hematologic values should have become normal
  • This regimen should be followed by 100 mcg monthly for life
  • Folic acid should be administered concomitantly if needed
  • Patients with Normal Intestinal Absorption Where the oral route is not deemed adequate, initial treatment similar to that for patients with pernicious anemia may be indicated depending on the severity of the deficiency
  • Chronic treatment should be with an oral B 12 preparation
  • If other vitamin deficiencies are present, they should be treated
  • Schilling Test The flushing dose is 1,000 mcg
  • Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit
Children

Intake in children should be in the amount (0.5 to 3 mcg daily) recommended by the Food and Nutrition Board, National Academy of Science-National Research Council.

While you are taking it
  • Patients with pernicious anemia should be informed that they will require monthly injections of vitamin B 12 for the remainder of their lives
  • Failure to do so will result in return of the anemia and in development of incapacitating and irreversible damage to the nerves of the spinal cord
  • Also, patients should be warned about the danger of taking folic acid in place of vitamin B 12 , because the former may prevent anemia but allow progression of subacute combined degeneration
  • A vegetarian diet which contains no animal products (including milk products or eggs) does not supply any vitamin B 12
  • Patients following such a diet, should be advised to take oral vitamin B 12 regularly. …
Talk to a doctor first if

Sensitivity to cobalt and/or vitamin B 12 is a contraindication.

Warnings

Patients with early Leber's disease (hereditary optic nerve atrophy) who were treated with cyanocobalamin suffered severe and swift optic atrophy. Hypokalemia and sudden death may occur in severe megaloblastic anemia which is treated intensely. Anaphylactic shock and death have been reported after parenteral vitamin B 12 administration. An intradermal test dose is recommended before cyanocobalamin injection is administered to patients suspected of being sensitive to this drug. This product contains benzyl alcohol. Benzyl alcohol has been reported to be associated with a fatal "Gasping Syndrome" in premature infants. This product contains aluminum that may be toxic. …

Effets secondaires possibles

Generalized: Anaphylactic shock and death have been reported with administration of parenteral vitamin B 12 (see WARNINGS ). Cardiovascular: Pulmonary edema and congestive heart failure early in treatment; peripheral vascular thrombosis Hematological: Polycythemia vera Gastrointestinal: Mild transient diarrhea Dermatological: Itching; transitory exanthema Miscellaneous: Feeling of swelling of entire body To report SUSPECTED ADVERSE REACTIONS, contact Meitheal Pharmaceuticals Inc. at 1-844-824-8426 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .

Pregnancy and breastfeeding

Pregnancy Teratogenic Effects Adequate and well-controlled studies have not been done in pregnant women. However, vitamin B 12 is an essential vitamin and requirements are increased during pregnancy. Amounts of vitamin B 12 that are recommended by the Food and Nutrition Board, National Academy of Science-National Research Council for pregnant women (4 mcg daily) should be consumed during pregnancy.

If you take too much

No overdosage has been reported with this drug.

En cas d'oubli

Prenez-le dès que vous y pensez, sauf s'il est presque l'heure de la dose suivante. Dans ce cas, sautez la dose oubliée. Ne prenez jamais deux doses à la fois pour compenser. Vérifiez votre notice, certains médicaments font exception.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-06-12.

Label for haemoglobin and chelated iron and cyanocobalamin and malt extract, the active ingredient registered with NAFDAC.

Check your pack of Jessy Haemoglobin Syrup

Add the expiry date on your pack for a full Trust Score.

Ou prenez la boîte en photo
Encore 3 vérifications gratuites aujourd'hui Official sources: U.S. FDA · EMA (EU) · Health Canada · WHO alerts

About Jessy Haemoglobin Syrup

What is in Jessy Haemoglobin Syrup?

Jessy Haemoglobin Syrup contains Haemoglobin; Chelated iron; Cyanocobalamin; Malt extract (5%; 0.3%; 0.0004%; 2%), as syrup, according to its NAFDAC registration record.

Is Jessy Haemoglobin Syrup registered with NAFDAC?

Yes. Jessy Haemoglobin Syrup is listed on the NAFDAC register under registration number A11-1301, and its registration is active as of 3 November 2026.

Has Jessy Haemoglobin Syrup been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Jessy Haemoglobin Syrup in our automatically synced alert list.

How can I check that my pack of Jessy Haemoglobin Syrup is genuine?

Run a free authenticity scan with the NAFDAC number A11-1301, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Jessy Haemoglobin Syrup?

Follow your prescription or the leaflet in your pack. The official label says: Avoid using the intravenous route. Use of this product intravenously will result in almost all of the vitamin being lost in the urine. Pernicious Anemia Parenteral vitamin B 12 is the recommended treatment and will be required for the remainder of the patient's life. The oral form is not dependable. A dose of 100 mcg daily for 6 or 7 days should be administered by intramuscular…

What is Jessy Haemoglobin Syrup used for?

Cyanocobalamin is indicated for vitamin B 12 deficiencies due to malabsorption which may be associated with the following conditions: Addisonian (pernicious) anemia Gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy Fish tapeworm infestation Malignancy of pancreas or bowel Folic acid deficiency I (Summarised from the official U.S. FDA label for haemoglobin and chelated iron and cyanocobalamin and malt extract. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Jessy Haemoglobin Syrup? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.